CDCA-lysine-niacin is a novel, innovative compound designed to support metabolic health and overall well-being. Combining the therapeutic properties of chenodeoxycholic acid (CDCA), lysine, and niacin, this product is formulated to promote healthy cholesterol levels, enhance liver function, and support cellular energy production. CDCA, a bile acid, aids in fat digestion and cholesterol regulation, while lysine, an essential amino acid, contributes to protein synthesis and immune function. Niacin, a vital B-vitamin, plays a key role in energy metabolism and cardiovascular health. Together, these components create a synergistic blend that targets multiple aspects of metabolic balance, making CDCA-lysine-niacin a promising solution for individuals seeking to optimize their health naturally.
Preparation Process: To prepare CDCA-lysine-niacin, dissolve chenodeoxycholic acid (CDCA) in anhydrous DMF under nitrogen. Add HOBt and EDC·HCl to activate the carboxyl group. Separately, dissolve L-lysine in DMF with TEA. Combine the solutions and stir at room temperature for 12 hours. Purify the CDCA-lysine intermediate by precipitation and washing. Next, dissolve niacin in DMF, add EDC·HCl and DMAP, then react with the CDCA-lysine intermediate for 6 hours. Purify the final product by column chromatography (silica gel, CH₂Cl₂/MeOH gradient) and lyophilize to obtain CDCA-lysine-niacin. Confirm purity by HPLC and NMR.
Usage Scenarios: CDCA-lysine-niacin is a synthetic compound combining chenodeoxycholic acid (CDCA), lysine, and niacin, designed to enhance metabolic and therapeutic effects. CDCA aids in bile acid regulation and cholesterol metabolism, lysine supports protein synthesis and tissue repair, while niacin (vitamin B3) improves lipid profiles and cardiovascular health. This combination may target metabolic disorders, such as hypercholesterolemia and fatty liver disease, by synergistically modulating lipid metabolism, reducing inflammation, and promoting cellular repair. It could also support liver function and improve insulin sensitivity, making it a potential candidate for managing metabolic syndrome and related conditions. Further research is needed to validate its efficacy and safety.